

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.35319428 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.22812865 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 7.17726449 |
| 4 | NADH metabolic process (GO:0006734) | 6.80518924 |
| 5 | actin filament depolymerization (GO:0030042) | 6.59555119 |
| 6 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.55748956 |
| 7 | adhesion of symbiont to host cell (GO:0044650) | 5.96507196 |
| 8 | virion attachment to host cell (GO:0019062) | 5.96507196 |
| 9 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.92099096 |
| 10 | vitamin A metabolic process (GO:0006776) | 5.88219637 |
| 11 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.73540500 |
| 12 | digestive system process (GO:0022600) | 5.67092598 |
| 13 | drug catabolic process (GO:0042737) | 5.63257708 |
| 14 | cellular glucuronidation (GO:0052695) | 5.48245445 |
| 15 | uronic acid metabolic process (GO:0006063) | 5.37208246 |
| 16 | glucuronate metabolic process (GO:0019585) | 5.37208246 |
| 17 | bile acid and bile salt transport (GO:0015721) | 5.12206941 |
| 18 | modified amino acid transport (GO:0072337) | 5.02900998 |
| 19 | regulation of cellular extravasation (GO:0002691) | 5.00046332 |
| 20 | glucose 6-phosphate metabolic process (GO:0051156) | 4.98714300 |
| 21 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.98637789 |
| 22 | response to hepatocyte growth factor (GO:0035728) | 4.98637789 |
| 23 | flavonoid metabolic process (GO:0009812) | 4.92927021 |
| 24 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.91852940 |
| 25 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.84546404 |
| 26 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.84546404 |
| 27 | adhesion of symbiont to host (GO:0044406) | 4.81873758 |
| 28 | lipoprotein transport (GO:0042953) | 4.59984864 |
| 29 | lipoprotein metabolic process (GO:0042157) | 4.59363915 |
| 30 | regulation of cGMP biosynthetic process (GO:0030826) | 4.50005884 |
| 31 | sulfate transmembrane transport (GO:1902358) | 4.46965798 |
| 32 | glycolipid catabolic process (GO:0019377) | 4.37440234 |
| 33 | digestion (GO:0007586) | 4.36387836 |
| 34 | peptide hormone processing (GO:0016486) | 4.35805751 |
| 35 | plasma lipoprotein particle assembly (GO:0034377) | 4.34872209 |
| 36 | glycosphingolipid catabolic process (GO:0046479) | 4.34307713 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.32422428 |
| 38 | peptide catabolic process (GO:0043171) | 4.30649153 |
| 39 | transepithelial transport (GO:0070633) | 4.30159082 |
| 40 | phospholipid efflux (GO:0033700) | 4.29927495 |
| 41 | intestinal epithelial cell development (GO:0060576) | 4.27566307 |
| 42 | hormone catabolic process (GO:0042447) | 4.25726444 |
| 43 | protein-lipid complex assembly (GO:0065005) | 4.21029639 |
| 44 | drinking behavior (GO:0042756) | 4.17783424 |
| 45 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.16931793 |
| 46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.13378568 |
| 47 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.09203107 |
| 48 | regulation of vitamin metabolic process (GO:0030656) | 4.02521186 |
| 49 | cholesterol efflux (GO:0033344) | 4.02228409 |
| 50 | fat-soluble vitamin metabolic process (GO:0006775) | 4.01553936 |
| 51 | renal system process involved in regulation of blood volume (GO:0001977) | 3.99142904 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 3.96952736 |
| 53 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.94960400 |
| 54 | sulfur compound transport (GO:0072348) | 3.94342825 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 3.94169363 |
| 56 | antibacterial humoral response (GO:0019731) | 3.94080687 |
| 57 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.93775793 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.93775793 |
| 59 | diacylglycerol metabolic process (GO:0046339) | 3.88571246 |
| 60 | cholesterol transport (GO:0030301) | 3.88347815 |
| 61 | sterol transport (GO:0015918) | 3.88347815 |
| 62 | antimicrobial humoral response (GO:0019730) | 3.85027879 |
| 63 | mRNA modification (GO:0016556) | 3.84753953 |
| 64 | bicarbonate transport (GO:0015701) | 3.84629095 |
| 65 | alkaloid metabolic process (GO:0009820) | 3.80676078 |
| 66 | cGMP biosynthetic process (GO:0006182) | 3.79465986 |
| 67 | vitamin transmembrane transport (GO:0035461) | 3.75786405 |
| 68 | killing of cells of other organism (GO:0031640) | 3.72066302 |
| 69 | disruption of cells of other organism (GO:0044364) | 3.72066302 |
| 70 | citrulline biosynthetic process (GO:0019240) | 3.70141116 |
| 71 | bile acid metabolic process (GO:0008206) | 3.69216318 |
| 72 | regulation of cGMP metabolic process (GO:0030823) | 3.69062126 |
| 73 | negative regulation of cholesterol transport (GO:0032375) | 3.66475802 |
| 74 | negative regulation of sterol transport (GO:0032372) | 3.66475802 |
| 75 | cellular response to nitric oxide (GO:0071732) | 3.65437195 |
| 76 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62959636 |
| 77 | arginine metabolic process (GO:0006525) | 3.60598805 |
| 78 | sulfate transport (GO:0008272) | 3.60202656 |
| 79 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.58360248 |
| 80 | vitamin transport (GO:0051180) | 3.57175047 |
| 81 | midgut development (GO:0007494) | 3.55295612 |
| 82 | * regulation of bile acid biosynthetic process (GO:0070857) | 3.55161556 |
| 83 | ceramide catabolic process (GO:0046514) | 3.54750543 |
| 84 | transcytosis (GO:0045056) | 3.54244141 |
| 85 | O-glycan processing (GO:0016266) | 3.52955943 |
| 86 | thyroid hormone metabolic process (GO:0042403) | 3.51651318 |
| 87 | drug transmembrane transport (GO:0006855) | 3.50807260 |
| 88 | vitamin D metabolic process (GO:0042359) | 3.50313041 |
| 89 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.49899370 |
| 90 | endocrine process (GO:0050886) | 3.49899370 |
| 91 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.49899370 |
| 92 | regulation of cholesterol homeostasis (GO:2000188) | 3.49242932 |
| 93 | sperm capacitation (GO:0048240) | 3.46954433 |
| 94 | oligosaccharide catabolic process (GO:0009313) | 3.46016600 |
| 95 | drug transport (GO:0015893) | 3.45989505 |
| 96 | glycosylceramide metabolic process (GO:0006677) | 3.45236501 |
| 97 | defense response to fungus (GO:0050832) | 3.44589627 |
| 98 | sphingomyelin metabolic process (GO:0006684) | 3.43784891 |
| 99 | heme transport (GO:0015886) | 3.41403586 |
| 100 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.39598706 |
| 101 | omega-hydroxylase P450 pathway (GO:0097267) | 3.38751212 |
| 102 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.34866353 |
| 103 | negative regulation of digestive system process (GO:0060457) | 3.32859136 |
| 104 | * cholesterol homeostasis (GO:0042632) | 3.32778298 |
| 105 | * sterol homeostasis (GO:0055092) | 3.31968573 |
| 106 | embryonic process involved in female pregnancy (GO:0060136) | 3.29829270 |
| 107 | vitamin biosynthetic process (GO:0009110) | 3.29738443 |
| 108 | cytidine metabolic process (GO:0046087) | 3.28942732 |
| 109 | cytidine catabolic process (GO:0006216) | 3.28942732 |
| 110 | cytidine deamination (GO:0009972) | 3.28942732 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.28180045 |
| 112 | urate metabolic process (GO:0046415) | 3.25977284 |
| 113 | striated muscle atrophy (GO:0014891) | 3.24917467 |
| 114 | glycerol metabolic process (GO:0006071) | 3.24174677 |
| 115 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.24015603 |
| 116 | glomerulus development (GO:0032835) | 3.22111725 |
| 117 | proline biosynthetic process (GO:0006561) | 3.19456950 |
| 118 | polyol transport (GO:0015791) | 3.19304191 |
| 119 | regulation of digestive system process (GO:0044058) | 3.17668064 |
| 120 | homocysteine metabolic process (GO:0050667) | 3.17571826 |
| 121 | epithelial structure maintenance (GO:0010669) | 3.15824337 |
| 122 | cellular carbohydrate catabolic process (GO:0044275) | 3.15690482 |
| 123 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.15640924 |
| 124 | nucleobase catabolic process (GO:0046113) | 3.15074647 |
| 125 | sphingolipid catabolic process (GO:0030149) | 3.14733229 |
| 126 | phenol-containing compound catabolic process (GO:0019336) | 3.14268910 |
| 127 | glycoside metabolic process (GO:0016137) | 3.14258667 |
| 128 | exogenous drug catabolic process (GO:0042738) | 3.12202094 |
| 129 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.11188818 |
| 130 | cellular response to reactive nitrogen species (GO:1902170) | 3.08738908 |
| 131 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.07644833 |
| 132 | regulation of actin nucleation (GO:0051125) | 3.04855903 |
| 133 | sulfation (GO:0051923) | 3.04179347 |
| 134 | regulation of systemic arterial blood pressure (GO:0003073) | 3.03732446 |
| 135 | thrombin receptor signaling pathway (GO:0070493) | 2.99182209 |
| 136 | fructose metabolic process (GO:0006000) | 2.92112353 |
| 137 | reverse cholesterol transport (GO:0043691) | 2.86603846 |
| 138 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.85813199 |
| 139 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.84589368 |
| 140 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.84107985 |
| 141 | purine nucleotide salvage (GO:0032261) | 2.83071188 |
| 142 | response to hydroperoxide (GO:0033194) | 2.80450396 |
| 143 | negative regulation of sodium ion transport (GO:0010766) | 2.79569943 |
| 144 | renal absorption (GO:0070293) | 2.79405629 |
| 145 | innate immune response in mucosa (GO:0002227) | 2.79226893 |
| 146 | urea metabolic process (GO:0019627) | 2.79012661 |
| 147 | urea cycle (GO:0000050) | 2.79012661 |
| 148 | skeletal muscle adaptation (GO:0043501) | 2.78796693 |
| 149 | drug metabolic process (GO:0017144) | 2.78785224 |
| 150 | positive regulation of p38MAPK cascade (GO:1900745) | 2.77312841 |
| 151 | intestinal absorption (GO:0050892) | 12.5662829 |
| 152 | intestinal cholesterol absorption (GO:0030299) | 12.0657969 |
| 153 | angiotensin maturation (GO:0002003) | 10.9959528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.29490292 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.63093508 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.74949110 |
| 4 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.02218943 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02077274 |
| 6 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.99424680 |
| 7 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.74473533 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.74276519 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.70580968 |
| 10 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.64612107 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.64512611 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.52294690 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.49558807 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.44386458 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.21413574 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16688971 |
| 17 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.16266337 |
| 18 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.06616918 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.92810700 |
| 20 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.88136804 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82623718 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81873603 |
| 23 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.81319406 |
| 24 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.75059317 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71323282 |
| 26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65542118 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.63669307 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.61623995 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58547778 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56899578 |
| 31 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.56684415 |
| 32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.56674355 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56447949 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53851637 |
| 35 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.50977548 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48861067 |
| 37 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.48654957 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44927337 |
| 39 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41859458 |
| 40 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.41736246 |
| 41 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37353973 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35720642 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34201331 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33686772 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32770588 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32160299 |
| 47 | GATA2_19941826_ChIP-Seq_K562_Human | 1.31213034 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31077601 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29085070 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26985830 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.26005789 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23230253 |
| 53 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23075998 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22880058 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22403325 |
| 56 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17943891 |
| 57 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16870997 |
| 58 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16862923 |
| 59 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.15977460 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15693505 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15380591 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14949482 |
| 63 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14758736 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13813702 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12749151 |
| 66 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.12668604 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11495998 |
| 68 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11270044 |
| 69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11131130 |
| 70 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07646181 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05772697 |
| 72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05054303 |
| 73 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.04475805 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03655223 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02081988 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01464950 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01249853 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00891488 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00885725 |
| 80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98747147 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98186145 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98090351 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96734281 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96286654 |
| 85 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96092633 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95794438 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94972786 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94401387 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94122208 |
| 90 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94095190 |
| 91 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94046149 |
| 92 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93192335 |
| 93 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93192335 |
| 94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93106560 |
| 95 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92945457 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92823248 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91947069 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90845039 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90328189 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90054366 |
| 101 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.89436236 |
| 102 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.89110609 |
| 103 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88677790 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87703580 |
| 105 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.87197306 |
| 106 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87009401 |
| 107 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86312029 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85417350 |
| 109 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85399969 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85390096 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85306720 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85012410 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83361444 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82826797 |
| 115 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.82634291 |
| 116 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.82355814 |
| 117 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82157653 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82036709 |
| 119 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81878252 |
| 120 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81248431 |
| 121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81199727 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.79106891 |
| 123 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78597749 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77807367 |
| 125 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77546471 |
| 126 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.77495379 |
| 127 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77424855 |
| 128 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.76893811 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75725609 |
| 130 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74784842 |
| 131 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.74701589 |
| 132 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.74341028 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.73435501 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73187270 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72615448 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.72019335 |
| 137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.68639069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.59934052 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.78097999 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 4.17000313 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.09242187 |
| 5 | MP0000462_abnormal_digestive_system | 3.50000928 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.39428872 |
| 7 | MP0003252_abnormal_bile_duct | 3.36540343 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 3.22950424 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.16705503 |
| 10 | MP0005365_abnormal_bile_salt | 2.97698758 |
| 11 | MP0003866_abnormal_defecation | 2.61231354 |
| 12 | MP0009840_abnormal_foam_cell | 2.59551610 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.55056367 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.39579978 |
| 15 | MP0000537_abnormal_urethra_morphology | 2.27394993 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.26577428 |
| 17 | MP0003283_abnormal_digestive_organ | 2.23008367 |
| 18 | MP0002822_catalepsy | 2.20349681 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 2.16357526 |
| 20 | MP0004147_increased_porphyrin_level | 2.13583845 |
| 21 | MP0000538_abnormal_urinary_bladder | 2.10897845 |
| 22 | MP0003878_abnormal_ear_physiology | 2.06557605 |
| 23 | MP0005377_hearing/vestibular/ear_phenot | 2.06557605 |
| 24 | MP0005409_darkened_coat_color | 2.03233338 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.01467674 |
| 26 | MP0001873_stomach_inflammation | 1.85521230 |
| 27 | MP0005381_digestive/alimentary_phenotyp | 1.82860507 |
| 28 | MP0009379_abnormal_foot_pigmentation | 1.81551703 |
| 29 | MP0001664_abnormal_digestion | 1.81251620 |
| 30 | MP0004043_abnormal_pH_regulation | 1.79685818 |
| 31 | MP0001663_abnormal_digestive_system | 1.74577583 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.70392353 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.60671279 |
| 34 | MP0000477_abnormal_intestine_morphology | 1.55917694 |
| 35 | MP0005670_abnormal_white_adipose | 1.51998798 |
| 36 | MP0000490_abnormal_crypts_of | 1.42997336 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.42267043 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.37884707 |
| 39 | MP0002089_abnormal_postnatal_growth/wei | 1.35415903 |
| 40 | MP0005448_abnormal_energy_balance | 1.33955117 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.33757392 |
| 42 | MP0005332_abnormal_amino_acid | 1.23980445 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.22559623 |
| 44 | MP0002796_impaired_skin_barrier | 1.20610165 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.16424800 |
| 46 | MP0006054_spinal_hemorrhage | 1.08410356 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.07967499 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.07535896 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.06999522 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.02257038 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.00120417 |
| 52 | MP0003868_abnormal_feces_composition | 0.98663377 |
| 53 | MP0002254_reproductive_system_inflammat | 0.97110454 |
| 54 | MP0009384_cardiac_valve_regurgitation | 0.96716249 |
| 55 | MP0009697_abnormal_copulation | 0.96506665 |
| 56 | MP0005535_abnormal_body_temperature | 0.96134882 |
| 57 | MP0004270_analgesia | 0.93835211 |
| 58 | MP0001765_abnormal_ion_homeostasis | 0.93590165 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 0.93160045 |
| 60 | MP0000516_abnormal_urinary_system | 0.91454749 |
| 61 | MP0005367_renal/urinary_system_phenotyp | 0.91454749 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 0.87804383 |
| 63 | MP0009115_abnormal_fat_cell | 0.86948120 |
| 64 | MP0000609_abnormal_liver_physiology | 0.83944951 |
| 65 | MP0009053_abnormal_anal_canal | 0.82783824 |
| 66 | MP0000230_abnormal_systemic_arterial | 0.82664355 |
| 67 | MP0004947_skin_inflammation | 0.81000433 |
| 68 | MP0010678_abnormal_skin_adnexa | 0.80727612 |
| 69 | MP0004858_abnormal_nervous_system | 0.80102039 |
| 70 | MP0002971_abnormal_brown_adipose | 0.78891357 |
| 71 | MP0002098_abnormal_vibrissa_morphology | 0.78456709 |
| 72 | MP0005501_abnormal_skin_physiology | 0.77566244 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.75989264 |
| 74 | MP0001764_abnormal_homeostasis | 0.73516493 |
| 75 | MP0001849_ear_inflammation | 0.71771729 |
| 76 | MP0005310_abnormal_salivary_gland | 0.71486231 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.70981638 |
| 78 | MP0003315_abnormal_perineum_morphology | 0.69940009 |
| 79 | MP0008004_abnormal_stomach_pH | 0.69660621 |
| 80 | MP0000467_abnormal_esophagus_morphology | 0.68553746 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.68392910 |
| 82 | MP0008872_abnormal_physiological_respon | 0.66986907 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 0.65964949 |
| 84 | MP0008469_abnormal_protein_level | 0.64595414 |
| 85 | MP0001845_abnormal_inflammatory_respons | 0.64236107 |
| 86 | MP0000470_abnormal_stomach_morphology | 0.62618285 |
| 87 | MP0005166_decreased_susceptibility_to | 0.61252549 |
| 88 | MP0006138_congestive_heart_failure | 0.58121551 |
| 89 | MP0000678_abnormal_parathyroid_gland | 0.56304129 |
| 90 | MP0005410_abnormal_fertilization | 0.56100867 |
| 91 | MP0000613_abnormal_salivary_gland | 0.55235492 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.55072264 |
| 93 | MP0005334_abnormal_fat_pad | 0.53876967 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.53743717 |
| 95 | MP0005395_other_phenotype | 0.53144057 |
| 96 | MP0003953_abnormal_hormone_level | 0.52127512 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.51989891 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.51316679 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.51008136 |
| 100 | MP0005266_abnormal_metabolism | 0.50563642 |
| 101 | MP0001756_abnormal_urination | 0.50402550 |
| 102 | MP0009764_decreased_sensitivity_to | 0.49336718 |
| 103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.49202323 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.48371155 |
| 105 | MP0000249_abnormal_blood_vessel | 0.47862418 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.47426342 |
| 107 | MP0003879_abnormal_hair_cell | 0.47085510 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.47030326 |
| 109 | MP0003941_abnormal_skin_development | 0.46682282 |
| 110 | MP0002166_altered_tumor_susceptibility | 0.46145864 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.45571698 |
| 112 | MP0000566_synostosis | 0.45420173 |
| 113 | MP0003119_abnormal_digestive_system | 0.45152356 |
| 114 | MP0003718_maternal_effect | 0.44963532 |
| 115 | MP0005451_abnormal_body_composition | 0.44922205 |
| 116 | MP0000604_amyloidosis | 0.43260757 |
| 117 | MP0002163_abnormal_gland_morphology | 0.43018321 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.41900509 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.41629400 |
| 120 | MP0000681_abnormal_thyroid_gland | 0.41177653 |
| 121 | MP0001191_abnormal_skin_condition | 0.40305207 |
| 122 | MP0003329_amyloid_beta_deposits | 0.39295662 |
| 123 | MP0002896_abnormal_bone_mineralization | 0.38927056 |
| 124 | MP0008260_abnormal_autophagy | 0.37654515 |
| 125 | MP0005174_abnormal_tail_pigmentation | 0.36952037 |
| 126 | MP0000598_abnormal_liver_morphology | 0.36598115 |
| 127 | MP0001188_hyperpigmentation | 0.36501140 |
| 128 | MP0002135_abnormal_kidney_morphology | 0.35657919 |
| 129 | MP0000627_abnormal_mammary_gland | 0.35309932 |
| 130 | MP0000427_abnormal_hair_cycle | 0.35129502 |
| 131 | MP0001881_abnormal_mammary_gland | 0.33940500 |
| 132 | MP0000377_abnormal_hair_follicle | 0.33717001 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.33539524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.38932217 |
| 2 | Acanthocytosis (HP:0001927) | 6.19382049 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 5.95648449 |
| 4 | Conjugated hyperbilirubinemia (HP:0002908) | 5.82273516 |
| 5 | Malnutrition (HP:0004395) | 5.40411621 |
| 6 | Hydroxyprolinuria (HP:0003080) | 5.15822323 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 5.15822323 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 4.97292686 |
| 9 | Chronic diarrhea (HP:0002028) | 4.81090427 |
| 10 | Fat malabsorption (HP:0002630) | 4.54574606 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 4.33280053 |
| 12 | Hyperglycinuria (HP:0003108) | 3.81661227 |
| 13 | Widely patent fontanelles and sutures (HP:0004492) | 3.80131854 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 3.76415659 |
| 15 | Poikilocytosis (HP:0004447) | 3.74348920 |
| 16 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.69946822 |
| 17 | Pigmentary retinal degeneration (HP:0001146) | 3.63448773 |
| 18 | Cupped ribs (HP:0000887) | 3.62550668 |
| 19 | Nausea (HP:0002018) | 3.61973380 |
| 20 | Gastrointestinal dysmotility (HP:0002579) | 3.49992470 |
| 21 | Abdominal distention (HP:0003270) | 3.45373568 |
| 22 | Abnormality of vitamin B metabolism (HP:0004340) | 3.45327229 |
| 23 | Abnormality of urine glucose concentration (HP:0011016) | 3.28890662 |
| 24 | Glycosuria (HP:0003076) | 3.28890662 |
| 25 | Facial shape deformation (HP:0011334) | 3.28095564 |
| 26 | Potter facies (HP:0002009) | 3.28095564 |
| 27 | Hypolipoproteinemia (HP:0010981) | 3.27735924 |
| 28 | Rectal prolapse (HP:0002035) | 3.27678998 |
| 29 | Dehydration (HP:0001944) | 3.21213817 |
| 30 | Steatorrhea (HP:0002570) | 3.18303762 |
| 31 | Confusion (HP:0001289) | 3.03707489 |
| 32 | Decreased circulating renin level (HP:0003351) | 2.98581176 |
| 33 | Intrahepatic cholestasis (HP:0001406) | 2.98356952 |
| 34 | Pustule (HP:0200039) | 2.95446941 |
| 35 | Abnormal biliary tract morphology (HP:0012440) | 2.93880045 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.90128456 |
| 37 | Progressive sensorineural hearing impairment (HP:0000408) | 2.88391006 |
| 38 | Congenital sensorineural hearing impairment (HP:0008527) | 2.85256534 |
| 39 | Abnormality of vitamin metabolism (HP:0100508) | 2.84213560 |
| 40 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.83005563 |
| 41 | Alkalosis (HP:0001948) | 2.81945789 |
| 42 | Hyperuricemia (HP:0002149) | 2.81937094 |
| 43 | Increased purine levels (HP:0004368) | 2.81937094 |
| 44 | Nephrolithiasis (HP:0000787) | 2.79272992 |
| 45 | Posterior subcapsular cataract (HP:0007787) | 2.77814709 |
| 46 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.77736421 |
| 47 | Villous atrophy (HP:0011473) | 2.77736421 |
| 48 | Increased mean platelet volume (HP:0011877) | 2.75557283 |
| 49 | Abnormality of chloride homeostasis (HP:0011422) | 2.75020161 |
| 50 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.74937529 |
| 51 | Abnormality of the gastric mucosa (HP:0004295) | 2.62836739 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.61880110 |
| 53 | Delayed epiphyseal ossification (HP:0002663) | 2.61111402 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.60241214 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 2.60241214 |
| 56 | Woolly hair (HP:0002224) | 2.58531844 |
| 57 | Abnormality of the 1st metacarpal (HP:0010009) | 2.56452843 |
| 58 | Progressive hearing impairment (HP:0001730) | 2.51842860 |
| 59 | Fragile skin (HP:0001030) | 2.51272166 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.46902221 |
| 61 | Abnormality of the costochondral junction (HP:0000919) | 2.44547746 |
| 62 | Hyperphosphaturia (HP:0003109) | 2.42865913 |
| 63 | Mesangial abnormality (HP:0001966) | 2.42515053 |
| 64 | Wide cranial sutures (HP:0010537) | 2.41976680 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.40875459 |
| 66 | Flat acetabular roof (HP:0003180) | 2.37542221 |
| 67 | Abnormal platelet volume (HP:0011876) | 2.37342618 |
| 68 | Xanthomatosis (HP:0000991) | 2.36636796 |
| 69 | Abnormal glucose tolerance (HP:0001952) | 2.36462993 |
| 70 | Thin bony cortex (HP:0002753) | 2.36293061 |
| 71 | Hypercholesterolemia (HP:0003124) | 2.36243993 |
| 72 | Hyperactive renin-angiotensin system (HP:0000841) | 2.35440684 |
| 73 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.30248283 |
| 74 | Subcapsular cataract (HP:0000523) | 2.28790146 |
| 75 | Epidermoid cyst (HP:0200040) | 2.27686923 |
| 76 | Reticulocytosis (HP:0001923) | 2.27625743 |
| 77 | Syncope (HP:0001279) | 2.27562705 |
| 78 | Male infertility (HP:0003251) | 2.22638548 |
| 79 | Abnormality of renin-angiotensin system (HP:0000847) | 2.22034027 |
| 80 | Milia (HP:0001056) | 2.19549876 |
| 81 | Hypotension (HP:0002615) | 2.18449931 |
| 82 | Symptomatic seizures (HP:0011145) | 2.18396482 |
| 83 | Cheilitis (HP:0100825) | 2.15401408 |
| 84 | Focal segmental glomerulosclerosis (HP:0000097) | 2.12099654 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11584150 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.11584150 |
| 87 | Abnormal urine phosphate concentration (HP:0012599) | 2.10743213 |
| 88 | Protuberant abdomen (HP:0001538) | 2.09668799 |
| 89 | Hyperammonemia (HP:0001987) | 2.06343446 |
| 90 | Ventricular fibrillation (HP:0001663) | 2.05949348 |
| 91 | Alopecia of scalp (HP:0002293) | 2.05731710 |
| 92 | Hyperphosphatemia (HP:0002905) | 2.04930963 |
| 93 | Renal tubular dysfunction (HP:0000124) | 2.04725483 |
| 94 | Cerebral palsy (HP:0100021) | 2.03682240 |
| 95 | Hypophosphatemic rickets (HP:0004912) | 2.03647781 |
| 96 | Metabolic acidosis (HP:0001942) | 2.02407417 |
| 97 | Increased IgE level (HP:0003212) | 2.02389331 |
| 98 | Urethral obstruction (HP:0000796) | 2.02267766 |
| 99 | Renal tubular acidosis (HP:0001947) | 2.01769412 |
| 100 | Ileus (HP:0002595) | 10.1170168 |
| 101 | Osteomalacia (HP:0002749) | 1.99336164 |
| 102 | Gout (HP:0001997) | 1.99046835 |
| 103 | Cone-rod dystrophy (HP:0000548) | 1.98945883 |
| 104 | Glomerulosclerosis (HP:0000096) | 1.97928285 |
| 105 | Proximal tubulopathy (HP:0000114) | 1.96697883 |
| 106 | Generalized aminoaciduria (HP:0002909) | 1.95915997 |
| 107 | Abnormality of nucleobase metabolism (HP:0010932) | 1.95545565 |
| 108 | Hemorrhage of the eye (HP:0011885) | 1.95317442 |
| 109 | Hypophosphatemia (HP:0002148) | 1.93429283 |
| 110 | Megaloblastic anemia (HP:0001889) | 1.92877101 |
| 111 | Irritability (HP:0000737) | 1.92070318 |
| 112 | Ureteral stenosis (HP:0000071) | 1.91893020 |
| 113 | Abnormal tarsal ossification (HP:0008369) | 1.90559406 |
| 114 | Goiter (HP:0000853) | 1.89570640 |
| 115 | Abnormal pancreas size (HP:0012094) | 1.89095676 |
| 116 | Biliary tract neoplasm (HP:0100574) | 1.86514673 |
| 117 | Hyperparathyroidism (HP:0000843) | 1.85427827 |
| 118 | Metabolic alkalosis (HP:0200114) | 1.85128662 |
| 119 | Eczematoid dermatitis (HP:0000976) | 1.84616078 |
| 120 | Pancreatitis (HP:0001733) | 1.84510187 |
| 121 | Hypocalcemia (HP:0002901) | 1.82888194 |
| 122 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.81258708 |
| 123 | Ureteral obstruction (HP:0006000) | 1.79984691 |
| 124 | Exocrine pancreatic insufficiency (HP:0001738) | 1.79829112 |
| 125 | Metaphyseal irregularity (HP:0003025) | 1.77638078 |
| 126 | Palpitations (HP:0001962) | 1.76763971 |
| 127 | Lethargy (HP:0001254) | 1.75372004 |
| 128 | Enlarged epiphyses (HP:0010580) | 1.74998010 |
| 129 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74020114 |
| 130 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.72128035 |
| 131 | Myopathic facies (HP:0002058) | 1.71774211 |
| 132 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.71177095 |
| 133 | Multiple lipomas (HP:0001012) | 1.70823648 |
| 134 | Petechiae (HP:0000967) | 1.69257051 |
| 135 | Plantar hyperkeratosis (HP:0007556) | 1.69178518 |
| 136 | Prolonged QT interval (HP:0001657) | 1.67672179 |
| 137 | Growth hormone excess (HP:0000845) | 1.67152295 |
| 138 | Hyperbilirubinemia (HP:0002904) | 1.67038330 |
| 139 | Gingivitis (HP:0000230) | 1.63343942 |
| 140 | Pili torti (HP:0003777) | 1.63290138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.81746636 |
| 2 | LMTK2 | 6.86768493 |
| 3 | FRK | 6.85675172 |
| 4 | MST4 | 4.96181937 |
| 5 | NME1 | 4.44566279 |
| 6 | MST1R | 3.59111574 |
| 7 | PRKG2 | 3.30003924 |
| 8 | RIPK1 | 2.82044961 |
| 9 | AKT3 | 2.74001405 |
| 10 | GRK6 | 2.56559768 |
| 11 | EPHA2 | 2.46458885 |
| 12 | NUAK1 | 2.22823605 |
| 13 | MAP3K10 | 2.15474780 |
| 14 | PTK6 | 1.96747851 |
| 15 | TAOK3 | 1.92144178 |
| 16 | MAP2K2 | 1.86585323 |
| 17 | EPHB2 | 1.68670553 |
| 18 | FGFR4 | 1.67911616 |
| 19 | MAP3K12 | 1.66216126 |
| 20 | NEK6 | 1.56126912 |
| 21 | MAP3K2 | 1.50721328 |
| 22 | TNIK | 1.41785893 |
| 23 | PIK3CA | 1.21591808 |
| 24 | MET | 1.19007061 |
| 25 | ERN1 | 1.18826226 |
| 26 | LATS1 | 1.17990047 |
| 27 | STK39 | 1.14261491 |
| 28 | STK10 | 1.13792764 |
| 29 | TTK | 1.10581357 |
| 30 | TRIB3 | 1.07229448 |
| 31 | DMPK | 1.07137768 |
| 32 | DDR2 | 1.02581518 |
| 33 | PIK3CG | 1.01774338 |
| 34 | ERBB2 | 1.00028706 |
| 35 | PIM1 | 1.00023791 |
| 36 | CASK | 0.99574820 |
| 37 | TESK1 | 0.97594512 |
| 38 | EPHB1 | 0.97131059 |
| 39 | MYLK | 0.95614554 |
| 40 | FGFR3 | 0.95381052 |
| 41 | WNK4 | 0.93936178 |
| 42 | PTK2 | 0.91605438 |
| 43 | TYK2 | 0.91355861 |
| 44 | PRKCI | 0.89825452 |
| 45 | MAPKAPK3 | 0.87587797 |
| 46 | PASK | 0.86050768 |
| 47 | EPHA4 | 0.83105069 |
| 48 | PRKAA2 | 0.81893784 |
| 49 | EPHA3 | 0.81203695 |
| 50 | MAP2K6 | 0.79512454 |
| 51 | CSF1R | 0.78782919 |
| 52 | OXSR1 | 0.77105329 |
| 53 | RET | 0.75694337 |
| 54 | FER | 0.74855801 |
| 55 | MAP3K7 | 0.72682910 |
| 56 | BMX | 0.71374314 |
| 57 | MATK | 0.70451754 |
| 58 | RIPK4 | 0.69146285 |
| 59 | PBK | 0.68945655 |
| 60 | PINK1 | 0.67816169 |
| 61 | RPS6KB2 | 0.66875631 |
| 62 | TAOK1 | 0.65182969 |
| 63 | BTK | 0.62406887 |
| 64 | MUSK | 0.61456530 |
| 65 | PKN2 | 0.61084832 |
| 66 | MAP3K8 | 0.60890501 |
| 67 | MAP3K11 | 0.60316525 |
| 68 | STK24 | 0.59467169 |
| 69 | TEC | 0.59442339 |
| 70 | GRK1 | 0.58009559 |
| 71 | BMPR2 | 0.57057464 |
| 72 | MELK | 0.53485114 |
| 73 | NLK | 0.53143756 |
| 74 | MAP2K1 | 0.51923970 |
| 75 | INSRR | 0.50454546 |
| 76 | MAP4K1 | 0.50317311 |
| 77 | STK3 | 0.48393521 |
| 78 | PRKAA1 | 0.45842927 |
| 79 | PDK2 | 0.45334442 |
| 80 | MAPK11 | 0.44711776 |
| 81 | PAK4 | 0.44223494 |
| 82 | ROCK1 | 0.42885187 |
| 83 | RPS6KB1 | 0.42551118 |
| 84 | PAK3 | 0.42355834 |
| 85 | AURKB | 0.41463175 |
| 86 | PDPK1 | 0.40774183 |
| 87 | SCYL2 | 0.38008142 |
| 88 | MAPKAPK2 | 0.37456754 |
| 89 | CDK12 | 0.37226105 |
| 90 | LRRK2 | 0.37220460 |
| 91 | SIK1 | 0.36905708 |
| 92 | TESK2 | 0.36504956 |
| 93 | IRAK1 | 0.35500005 |
| 94 | DYRK1B | 0.35472627 |
| 95 | IKBKE | 0.35100721 |
| 96 | CSK | 0.33473364 |
| 97 | KSR2 | 0.32676894 |
| 98 | NEK1 | 0.32608979 |
| 99 | STK11 | 0.32077722 |
| 100 | TBK1 | 0.31540172 |
| 101 | BCR | 0.31299350 |
| 102 | KIT | 0.30858916 |
| 103 | JAK2 | 0.30627972 |
| 104 | MAP3K3 | 0.29872444 |
| 105 | PRKCA | 0.29855023 |
| 106 | SYK | 0.29569401 |
| 107 | MAP3K1 | 0.29016417 |
| 108 | PAK2 | 0.27873290 |
| 109 | CAMK2D | 0.27669068 |
| 110 | JAK1 | 0.27605919 |
| 111 | MAP3K9 | 0.27505427 |
| 112 | ICK | 0.27216280 |
| 113 | RPS6KA2 | 0.26976599 |
| 114 | SRC | 0.26608536 |
| 115 | ERBB4 | 0.25109541 |
| 116 | EEF2K | 0.25059342 |
| 117 | CHUK | 0.23606578 |
| 118 | PRKCQ | 0.22977274 |
| 119 | PDK1 | 0.22773320 |
| 120 | PRKACA | 0.22754875 |
| 121 | CAMK1D | 0.22383102 |
| 122 | PDGFRA | 0.21395921 |
| 123 | CAMKK1 | 0.20769084 |
| 124 | STK38L | 0.20414821 |
| 125 | CSNK1A1 | 0.20380019 |
| 126 | FYN | 0.20267262 |
| 127 | PRKACG | 0.19684523 |
| 128 | IRAK3 | 0.19491003 |
| 129 | BMPR1B | 0.17406927 |
| 130 | PRKCZ | 0.17316734 |
| 131 | PRKCD | 0.16523254 |
| 132 | GSK3A | 0.16464845 |
| 133 | AKT2 | 0.15565758 |
| 134 | CDC42BPA | 0.15186532 |
| 135 | FGR | 0.13902544 |
| 136 | ITK | 0.11651311 |
| 137 | PAK1 | 0.11186245 |
| 138 | PDK4 | 0.10705838 |
| 139 | PDK3 | 0.10705838 |
| 140 | CAMK2B | 0.10451442 |
| 141 | CAMK2G | 0.09815166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.41575063 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 5.21776624 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.42608386 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 4.10769047 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.73713121 |
| 6 | Galactose metabolism_Homo sapiens_hsa00052 | 2.90635202 |
| 7 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.80226938 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.79537033 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.75188623 |
| 10 | Bile secretion_Homo sapiens_hsa04976 | 2.60657539 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.50753529 |
| 12 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.45866615 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.44812165 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.97753010 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.96528117 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86756489 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76129542 |
| 18 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.75876592 |
| 19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.68140487 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.66952537 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43463145 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41505642 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.40393203 |
| 24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.28949652 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27287647 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.25463545 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21610277 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20300234 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19094643 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18692770 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11723793 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.09275636 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08155248 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99683150 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96623766 |
| 36 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93105247 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88452486 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87291505 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86743528 |
| 40 | Tight junction_Homo sapiens_hsa04530 | 0.81185963 |
| 41 | Asthma_Homo sapiens_hsa05310 | 0.72266346 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72109715 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70832466 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65960872 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64425528 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63617820 |
| 47 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61648853 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61509178 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61251557 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60167945 |
| 51 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56257494 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55122779 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53653715 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.53101745 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51587303 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44005358 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43741111 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43301445 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42993269 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.41553101 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41051407 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40651857 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.40047627 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38822112 |
| 65 | Insulin secretion_Homo sapiens_hsa04911 | 0.38316720 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38075887 |
| 67 | Adherens junction_Homo sapiens_hsa04520 | 0.37979309 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36824083 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36821193 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.35807965 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.35739246 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 0.35649169 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35259122 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32647697 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31726826 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30752615 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30657495 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30599812 |
| 79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.30372642 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.29810896 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29545200 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26213700 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.25972564 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25119060 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.24944474 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.24178814 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.23173190 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.22344557 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.22139367 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20789416 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20163427 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.19531006 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.18433012 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18163782 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.16738989 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.16676362 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15551738 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.14607603 |
| 99 | Other glycan degradation_Homo sapiens_hsa00511 | 0.14129900 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14127398 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.14002875 |
| 102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.13766750 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13565988 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.12164622 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12077265 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.11391925 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.10765964 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10737600 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10552991 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.09862168 |
| 111 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.09025764 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.08854465 |
| 113 | Gap junction_Homo sapiens_hsa04540 | 0.07467510 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.06797531 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06522982 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.05383183 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.04308806 |
| 118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.03422076 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.02970308 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.02738279 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.01587236 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.01365985 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.00188434 |
| 124 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0405479 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0134383 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | -0.0081961 |

